openPR Logo
Press release

HIV Drugs Market 2022-30 : Industry Analysis, Size, Share, Growth And Forecast | Gilead Sciences, Inc, GlaxoSmithKline plc., Johnson & Johnson, Merck & Co., Inc., Boehringer Ingelheim International GmbH

11-17-2022 06:34 AM CET | Health & Medicine

Press release from: The Business research company

HIV Drugs Market

HIV Drugs Market

Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!

According to The Business Research Company's HIV Drugs market report, the HIV drugs market reached a value of nearly $30,520.0 million in 2020, having increased at a compound annual growth rate (CAGR) of 8.1% since 2015. The market is expected to grow from $30,520.0 million in 2020 to $36,460.0 million in 2025 at a rate of 3.6%. The HIV drug market growth is mainly due to the growing prevalence of HIV and government initiatives which is expected to drive the demand for HIV drugs. The HIV drugs market is expected to grow from $36,460.0 million in 2025 to $40,303.1 million in 2030 at a CAGR of 2.0%.

Government initiatives and efforts towards implementing reforms have had a significant impact on the market, in both developed and developing countries. For instance, the Health Resources and Services Administration's (HRSA) Bureau of Primary Health Care announced the availability of around $83 million for up to 300 health centers for the fiscal year 2021 Ending the HIV Epidemic- Primary Care HIV Prevention (PCHP) program. The PCHP funding is likely to expand HIV prevention services with the motive of decreasing the risk of HIV transmission across 57 geographic locations recognized by Ending the HIV Epidemic: A Plan for America.

View Our Buying Options For The HIV Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=4060

The HIV Drugs market is segmented -
• By Type : Nucleoside Reverse Transcriptase Inhibitors (NRT's), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT's), Protease Inhibitors, Integrase Strand Transfer Inhibitors (INSTIs)
• By Application : Hospital Pharmacies, Retail Pharmacies
• By Administration : Oral, Parenteral
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the HIV Drugs market.

Major competitors in the HIV Drugs market include Gilead Sciences, Inc, GlaxoSmithKline plc., Johnson & Johnson, Merck & Co., Inc., Boehringer Ingelheim International GmbH

See The Full HIV Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/hiv-drugs-market

The HIV drug market consists of sales of human immunodeficiency virus (HIV) drugs used for the treatment of HIV infection. The market consists of revenue generated by the anti-retroviral (ARV) drug companies manufacturing anti-retroviral drugs such as nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), entry and fusion inhibitors, integrase inhibitors, and protease inhibitors (PIs) for the treatment of a HIV infection.

The Table Of Content For The HIV Drugs Market Include:
1. HIV Drugs Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
……
22 Key Mergers And Acquisitions In The HIV Drugs Market
23 HIV Drugs Market Opportunities And Strategies
24 HIV Drugs Market Conclusions And Recommendations
25 Appendix

The Business Research Company's "Global HIV Drugs Opportunities And Strategies Market Report - Forecast To 2030" is the most comprehensive report available in market, providing data and statistics from over 60 geographies analyzed in more than 2500 market segments. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. Additionally, it evaluates the market's historic and projected growth and identifies significant trends and strategies that can be used to outperform the competitors in the sector.

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany/
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Interested to know more about The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. Located globally, it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release HIV Drugs Market 2022-30 : Industry Analysis, Size, Share, Growth And Forecast | Gilead Sciences, Inc, GlaxoSmithKline plc., Johnson & Johnson, Merck & Co., Inc., Boehringer Ingelheim International GmbH here

News-ID: 2810541 • Views: 191

More Releases from The Business research company

Enterprise Governance, Risk And Compliance (EGRC) Market Market Forecast 2032: C …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 Enterprise Governance, Risk And Compliance (EGRC) Market Size, Growth Rate, And Forecast The global enterprise governance, risk and compliance (egrc) market size grew from $33.29 billion in 2022 to $38.26 billion in 2023 at a compound annual growth rate (CAGR) of 14.9%. The Russia-Ukraine war disrupted the chances
Single-Photon Emission Computed Tomography (SPECT) Market Trends, Top Companies, …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 Employment Screening Services Market Size, Growth Rate, And Forecast The global employment screening services market size grew from $4.46 billion in 2022 to $4.82 billion in 2023 at a compound annual growth rate (CAGR) of 8.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from
Emotion Detection and RecognitionMarket Analysis, Trends, Growth, Research And F …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 Emotion Detection And Recognition Market Size, Growth Rate, And Forecast The global emotion detection and recognition market size grew from $21.88 billion in 2022 to $25.32 billion in 2023 at a compound annual growth rate (CAGR) of 15.7%. The Russia-Ukraine war disrupted the chances of global economic
Enterprise Asset Management Market 2023 - Size, Growth Rate, Top Companies, Regi …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 Enterprise Asset Management Market Size, Growth Rate, And Forecast The global enterprise asset management market size grew from $5.75 billion in 2022 to $6.39 billion in 2023 at a compound annual growth rate (CAGR) of 11.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the

All 5 Releases


More Releases for HIV

HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral